» Articles » PMID: 36233680

Analysis of the Validity of Perioperative Antibiotic Prophylaxis in Maxillofacial Surgery

Overview
Journal J Clin Med
Specialty General Medicine
Date 2022 Oct 14
PMID 36233680
Authors
Affiliations
Soon will be listed here.
Abstract

Perioperative antibiotic prophylaxis is the standard in surgical departments. The type of operation, the duration of the procedure, the degree of microbiological purity of the operating field and the current clinical condition of the patient determine its administration. The aim of this study was to validate the antibiotic prophylaxis used in a Maxillofacial Surgery Department for a group of trauma and non-trauma patients. To that end, an observational prospective cohort study was carried out. The study was conducted on a group of 83 patients of the Department of Cranio-Maxillo-Facial Surgery who were divided into a group of trauma patients ( = 43) and one of non-trauma patients ( = 40). In both groups, the classic microbiological tests were carried out, and the results were analyzed in relation to: the study group, age, sex, duration of surgery, type of surgical access. Most bacterial strains were isolated at the initial stage of the operation. Gram (+) cocci were isolated more often in the trauma group and Gram (-) rods in the non-trauma group. Significantly more often, strains of fungi were noted in the initial stage of the procedure in the trauma group. We conclude that the use of perioperative antibiotic prophylaxis in the Maxillofacial Surgery Departments is justified.

References
1.
Lindeboom J, van den Akker H . A prospective placebo-controlled double-blind trial of antibiotic prophylaxis in intraoral bone grafting procedures: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003; 96(6):669-72. DOI: 10.1016/j.tripleo.2003.08.026. View

2.
Remschmidt B, Gaessler J, Wallner J, Zemann W, Schwaiger M . Surgical site infections in orthognathic surgery: prolonged versus single-dose antibiotic prophylaxis. Int J Oral Maxillofac Surg. 2022; 52(2):219-226. DOI: 10.1016/j.ijom.2022.06.002. View

3.
Karakida K, Aoki T, Ota Y, Yamazaki H, Otsuru M, Takahashi M . Analysis of risk factors for surgical-site infections in 276 oral cancer surgeries with microvascular free-flap reconstructions at a single university hospital. J Infect Chemother. 2010; 16(5):334-9. DOI: 10.1007/s10156-010-0108-y. View

4.
Davis C, Gregoire C, Steeves T, Demsey A . Prevalence of Surgical Site Infections Following Orthognathic Surgery: A Retrospective Cohort Analysis. J Oral Maxillofac Surg. 2016; 74(6):1199-206. DOI: 10.1016/j.joms.2016.01.040. View

5.
Iocca O, Copelli C, Ramieri G, Zocchi J, Savo M, Di Maio P . Antibiotic prophylaxis in head and neck cancer surgery: Systematic review and Bayesian network meta-analysis. Head Neck. 2021; 44(1):254-261. DOI: 10.1002/hed.26908. View